Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report)'s share price gapped down prior to trading on Tuesday following a dissappointing earnings announcement. The stock had previously closed at $70.02, but opened at $66.26. Henry Schein shares last traded at $64.93, with a volume of 316,951 shares trading hands.
The company reported $1.10 EPS for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. During the same quarter last year, the firm earned $1.23 EPS. Henry Schein's revenue was up 3.3% on a year-over-year basis.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on HSIC. Robert W. Baird reissued a "neutral" rating and set a $72.00 target price (down from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Wells Fargo & Company cut their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Leerink Partners set a $75.00 price target on shares of Henry Schein in a report on Monday, July 14th. Stifel Nicolaus reaffirmed a "hold" rating and issued a $75.00 price target (down from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Finally, Piper Sandler cut their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Nine investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $78.08.
Get Our Latest Research Report on HSIC
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the business. Investment Management Corp VA ADV acquired a new position in shares of Henry Schein in the 4th quarter valued at about $32,000. Rakuten Securities Inc. bought a new position in shares of Henry Schein during the first quarter worth about $34,000. ANTIPODES PARTNERS Ltd bought a new position in shares of Henry Schein during the second quarter worth about $43,000. Steph & Co. bought a new position in shares of Henry Schein during the second quarter worth about $44,000. Finally, CX Institutional grew its position in shares of Henry Schein by 107.3% during the second quarter. CX Institutional now owns 651 shares of the company's stock worth $48,000 after acquiring an additional 337 shares during the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.
Henry Schein Stock Down 8.9%
The firm's 50-day moving average price is $71.58 and its 200 day moving average price is $71.30. The firm has a market cap of $7.77 billion, a P/E ratio of 20.08, a price-to-earnings-growth ratio of 2.20 and a beta of 0.81. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50.
About Henry Schein
(
Get Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.